$PCTNeutralMed

PureCycle Announces Pricing of Concurrent Public Offerings of 4.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $395.0 Million

PureCycle Technologies priced concurrent underwritten offerings: $250.0 million aggregate principal of 4.75% convertible senior notes due 2032 and 17,661,388 shares of common stock at $8.21 per share, for $395.0 million gross proceeds, according to the company. Net proceeds are estimated at ~$242.0 million (notes) and ~$137.1 million (stock). Expected to close around June 15, 2026. Proceeds will fund repurchases of its 7.25% green convertible notes due 2030 and general purposes.

8/10
9/10
Med
Neutral
priced June 11; expected to close around June 15, 2026
Neutral-to-slightly negative for equity due to dilution, partially offset by refinancing/repurchase of higher-coupon convertibles.

The deal is a capital-structure event: new convertibles + equity issuance to fund cash repurchases of 7.25% green convertibles due 2030.

PureCycle priced a concurrent $250M 4.75% convertible notes offering and 17.66M common shares, raising $395M gross and funding green note repurchases.

Near-term volatility likely around dilution/financing optics and convertible overhang; medium-term depends on whether repurchase reduces interest burden and improves balance-sheet risk.

Background

PureCycle is issuing new 2032 convertibles and common stock concurrently under a shelf registration, with proceeds earmarked to repurchase its 2030 green convertible notes.

Why it matters

Net proceeds are explicitly allocated to cash repurchase of $216M aggregate principal of the 7.25% green convertible notes due 2030 (plus potential additional repurchases), with remaining proceeds for working capital and general corporate purposes. This changes both equity share count and the company’s interest/convertible maturity ladder.

Market relevance

A priced convertible + equity raise with stated use of proceeds to refinance/repurchase existing convertibles is a direct catalyst for PCT’s equity dilution, convertible hedging, and credit risk perception.

Market effects

Convertible + equity financing may signal continued reliance on capital markets for balance-sheet management in recycling/industrial tech.

Primarily US-listed capital markets; limited direct regional spillover beyond Nasdaq credit/equity sentiment.

Refinancing of convertibles can affect global convertible-bond investor positioning, but impact is company-specific.

Alternative perspectives

The repurchase target is sizable and could reduce future coupon/financing risk; if the market views the refinancing as value-accretive, the equity reaction could be less negative than dilution implies.

Conversion mechanics (initial conversion price ~35% premium) and the ability to settle conversions in stock/cash can materially affect hedging flows and near-term trading dynamics around the offering and close.

Key entities

  • PureCycle Technologies, Inc.

    Priced concurrent offerings: $250M 4.75% convertible notes due 2032 and 17,661,388 shares of common stock; gross proceeds $395M.

  • 7.25% green convertible notes due 2030

    PureCycle plans to repurchase for cash approximately $216M principal at maturity using proceeds from the new offerings.

  • 4.75% convertible senior notes due 2032

    New notes accrue 4.75% interest, mature July 1, 2032, and include conversion and redemption/repurchase features.

  • Morgan Stanley

    Sole bookrunner for each offering.

Related articles

$PCTMedAI 8/10

PureCycle Announces Closing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock

PureCycle Technologies (NASDAQ: PCT) said it closed concurrent public offerings of $287.5 million aggregate principal 4.75% convertible senior notes due 2032 and 19,854,000 shares of common stock, including full underwriter over-allotments. Morgan Stanley was sole bookrunner. Net proceeds were about $432.5 million; PureCycle plans to use about $246.3 million to repurchase $216.0 million of its 7.25% Green Convertible Notes due 2030 and the rest for other purposes.

$PCTMedAI 9/10

PureCycle Announces Proposed Concurrent Public Offerings of Convertible Senior Notes and Common Stock

PureCycle Technologies (Nasdaq: PCT) said it has started underwritten concurrent offerings: $250.0 million of convertible senior notes due 2032 and $145.0 million of common stock. It plans 30-day underwriter over-allotment options for up to $37.5 million more notes and $18.75 million more shares. Net proceeds would fund repurchases of its 7.25% green convertible notes due 2030 and general corporate use, with Morgan Stanley as sole bookrunner.

$PCTMedAI 9/10

PureCycle (PCT) Adds 6 % on PureFive Living Hinge Cap Success

PureCycle Technologies (NASDAQ:PCT) shares rose 6.11% to $13.63 after the company said it successfully produced a living hinge cap using its PureFive resin. PureCycle said the cap met mechanical performance requirements typically met by virgin polypropylene, based on collaboration with StackTeck. The article also notes PureCycle received ISO 9001:2015 certification from DQS Global.